(I)PD patients who developed cognitive impairment during the study had higher CSF levels of TNF-alpha at baseline compared to patients without the development of cognitive impairment and compared to patients who presented with cognitive impairment already at baseline. This evidence concerns the gene TNF and Parkinson disease.